What is HC Wainwright’s Estimate for Altimmune Q2 Earnings?
Altimmune, Inc. (NASDAQ:ALT – Free Report) – Stock analysts at HC Wainwright cut their Q2 2025 earnings estimates for shares of Altimmune in a report released on Monday, March 3rd. HC Wainwright analyst P. Trucchio now forecasts that the company will post earnings of ($0.34) per share for the quarter, down from their previous forecast […]
